OPKO Health Launches Drive-Thru Coronavirus Testing in New York
OPKO Health's (NASDAQ: OPK) BioReference Labs business unit is the latest company to develop a test for SARS-CoV-2, the coronavirus that causes COVID-19. The company announced Friday it's accepting specimens for testing from healthcare providers nationwide, and that it is working with the New York State Department of Health to create a drive-thru testing facility in New Rochelle, N.Y., a community just north of The Bronx that has been hard hit by the epidemic.
IMAGE SOURCE: GETTY IMAGES.
The healthcare company's drive-thru testing site will be the first of its kind on the East Coast, and is expected to be able to handle up to 200 cars per day. The company expects to have the capacity to conduct 5,000 tests daily at other testing sites in New York beginning next week, too.
Source Fool.com
